Therefore, we speculated that OI patients could had insufficient secretion of LCN2 from bone, which could increase food intake and then increase the risk of obesity and disorders of glucose metabolism. The gene discussed is LCN2; the disease is obesity due to melanocortin 4 receptor deficiency.